Loading...
Docoh

Panbela Therapeutics (PBLA)

News

From Benzinga Pro
Panbela Therapeutics: Q1 Earnings Insights
12 May 22
Earnings
Panbela Therapeutics (NASDAQ:PBLA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Panbela Therapeutics Q1 EPS $(0.27) Misses $(0.25) Estimate
12 May 22
Earnings, News
Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 17.39 percent decrease over losses of $(0.23) per share
Earnings Scheduled For May 12, 2022
12 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
25 Mar 22
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Panbela Therapeutics Q4 EPS $(0.26) Misses $(0.18) Estimate
24 Mar 22
Earnings, News
Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 188.89 percent decrease over losses of $(0.09) per
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
24 Mar 22
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For March 24, 2022
24 Mar 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter.
Preview: Panbela Therapeutics's Earnings
23 Mar 22
Earnings
Panbela Therapeutics (NASDAQ:PBLA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that Panbela Therapeutics will report an earnings per share (EPS) of $-0.18.
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
20 Mar 22
Biotech, News, Penny Stocks, Small Cap, FDA, Top Stories, General
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.
Panbela Therapeutics Acquires Cancer Prevention Pharmaceuticals For Stock & Milestone Payment
22 Feb 22
Biotech, M&A, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
Panbela Therapeutics Inc (NASDAQ: PBLA) has
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.; Under Terms, Holders Of Panbela Are Expected To Own ~59% Of Post-Merger Holding Co.
22 Feb 22
M&A
Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address considerable unmet needs Combined pipeline extends from pre-clinical to registration studies,

Press releases

From Benzinga Pro
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates IIN, PBLA, TEN, REGI
5 May 22
Small Cap, Press Releases
NEW YORK, May 5, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sh
PANBELA THERAPEUTICS INVESTOR ALERT - Kuznicki Law PLLC Investigates Panbela Therapeutics, Inc. - PBLA
4 May 22
Press Releases
Kuznicki Law PLLC is investigating the proposed sale of Cancer Prevention Pharmaceuticals, Inc. to Panbela Therapeutics, Inc. ("the Company") (NasdaqCM: PBLA). Under the terms of the proposed transaction, holders of
Panbela to Host Virtual R&D Day
27 Apr 22
Press Releases
MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, will
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - CDK, PBLA, SJI, OBNK, ZWS
7 Apr 22
Press Releases
NEW YORK, April 7, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties
PANBELA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Panbela Therapeutics, Inc. - PBLA
7 Apr 22
Press Releases
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cancer Prevention Pharmaceuticals, Inc. to Panbela
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
24 Mar 22
Earnings, Press Releases
MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today provides a business
Panbela to Participate in a Panel Discussion: "Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology," at the Maxim Virtual Growth Conference on March 28, 2022, at 12:00 pm ET
23 Mar 22
Press Releases
MINNEAPOLIS, March 23, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer,
Panbela to Participate in the 34th Annual Roth Conference
10 Mar 22
Press Releases
MINNEAPOLIS, March 10, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer,
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates MTOR, TEN, DWIN, PBLA
28 Feb 22
Press Releases
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties
Lifshitz Law PLLC Announces Investigation of APR, EXTN, MCAE, and PBLA
26 Feb 22
News, Legal, Press Releases
NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (NASDAQ:APR) Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of APR to Owens & Minor, Inc.
PANBELA THERAPEUTICS INVESTOR ALERT By The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Panbela Therapeutics, Inc. - PBLA
25 Feb 22
Press Releases
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cancer Prevention Pharmaceuticals, Inc. to Panbela
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates HMHC, TGNA, MTOR, PBLA
23 Feb 22
Legal, Press Releases
NEW YORK, NY / ACCESSWIRE / February 23, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary
Lifshitz Law PLLC Announces Investigation of EXTN, MTOR, PBLA, and ECOL
23 Feb 22
Legal, Press Releases
NEW YORK, NY / ACCESWIRE / February 23, 2022 /Exterran Corporation (NYSE:EXTN)Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of EXTN to Enerflex Ltd.If you
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates HMHC, TGNA, MTOR, PBLA
22 Feb 22
Press Releases
NEW YORK, Feb. 22, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties
PBLA Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Panbela Therapeutics, Inc. Is Fair to Shareholders
22 Feb 22
Press Releases
Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Panbela Therapeutics, Inc. (NASDAQ:PBLA) and Cancer Prevention Pharmaceuticals, Inc. is fair to Panbela shareholders. Halper Sadeh